303 related articles for article (PubMed ID: 27261608)
21. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
Furuya K; Sasaki A; Tsunoda Y; Tsuji M; Udaka Y; Oyamada H; Tsuchiya H; Oguchi K
Hum Cell; 2016 Apr; 29(2):76-82. PubMed ID: 26573286
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs and cancer: towards a personalized medicine.
Fabbri M
Curr Mol Med; 2013 Jun; 13(5):751-6. PubMed ID: 23642056
[TBL] [Abstract][Full Text] [Related]
23. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN
Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550
[TBL] [Abstract][Full Text] [Related]
24. miRNAs in breast cancer: ready for real time?
Krell J; Frampton AE; Jacob J; Castellano L; Stebbing J
Pharmacogenomics; 2012 Apr; 13(6):709-19. PubMed ID: 22515613
[TBL] [Abstract][Full Text] [Related]
25. Small players with big roles: microRNAs as targets to inhibit breast cancer progression.
Greene SB; Herschkowitz JI; Rosen JM
Curr Drug Targets; 2010 Sep; 11(9):1059-73. PubMed ID: 20545613
[TBL] [Abstract][Full Text] [Related]
26. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
Lan H; Lu H; Wang X; Jin H
Biomed Res Int; 2015; 2015():125094. PubMed ID: 25874201
[TBL] [Abstract][Full Text] [Related]
28. Small is beautiful: microRNAs and breast cancer-where are we now?
Verghese ET; Hanby AM; Speirs V; Hughes TA
J Pathol; 2008 Jul; 215(3):214-21. PubMed ID: 18446835
[TBL] [Abstract][Full Text] [Related]
29. The role of microRNAs in melanoma.
Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
[TBL] [Abstract][Full Text] [Related]
30. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis.
Shi M; Liu D; Duan H; Shen B; Guo N
Cancer Metastasis Rev; 2010 Dec; 29(4):785-99. PubMed ID: 20938719
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
32. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer.
Hemmatzadeh M; Mohammadi H; Karimi M; Musavishenas MH; Baradaran B
Biomed Pharmacother; 2016 Aug; 82():509-19. PubMed ID: 27470391
[TBL] [Abstract][Full Text] [Related]
33. The role of microRNA in resistance to breast cancer therapy.
Robertson NM; Yigit MV
Wiley Interdiscip Rev RNA; 2014; 5(6):823-33. PubMed ID: 25044299
[TBL] [Abstract][Full Text] [Related]
34. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
35. The role of microRNAs in the pathogenesis and treatment of hematopoietic malignancies.
Schmid CA; Craig VJ; Müller A; Flori M
Curr Pharm Des; 2013; 19(7):1201-10. PubMed ID: 23092340
[TBL] [Abstract][Full Text] [Related]
36. The involvement of microRNAs in malignant transformation.
Rutnam ZJ; Yang BB
Histol Histopathol; 2012 Oct; 27(10):1263-70. PubMed ID: 22936445
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs in Oncogenesis and Tumor Suppression.
Barbato S; Solaini G; Fabbri M
Int Rev Cell Mol Biol; 2017; 333():229-268. PubMed ID: 28729026
[TBL] [Abstract][Full Text] [Related]
38. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
Liu B; Tian Y; Li F; Zhao Z; Jiang X; Zhai C; Han X; Zhang L
Oncol Rep; 2016 Jun; 35(6):3178-84. PubMed ID: 27109339
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA function in cancer: oncogene or a tumor suppressor?
Shenouda SK; Alahari SK
Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
